Gateway(R) entry vector of human epidermal growth factor receptor (EGFR), EGFR-tyrosine kinase inhibitor (TKI) resistant and activating mutations.
|
Other clones in our bank
External Database human EGFR Reference sequence |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Terms and conditions for distribution | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of literature designated by the DEPOSITOR is requested. (Uchibori, K et al. Nat. Commun. 8: 14768, 2017) |
---|---|
Ordering | Please visit Information of Request for Distribution.[link] Order form [Credit Card Payment ![]() ![]() Material Transfer Agreement (MTA for use for not-for-profit academic purpose) [Word ![]() |
Remarks | Gateway® Entry clone. Please refer Life Technologies Corporation signs license agreement with RIKEN BRC. |
提供条件 | 利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する(Uchibori, K et al. Nat. Commun. 8: 14768, 2017)。 |
---|---|
提供依頼 | 手続きの詳細は、「提供申込みについて[link]」をご覧ください。 提供依頼書 [Word ![]() 提供同意書 (MTA、非営利機関による非営利学術研究用)[Word ![]() |
備考 | Gateway®テクノロジーを用いたエントリークローンです。「Gateway®テクノロジーを用いたクローンの提供と寄託のご案内」をご覧ください。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB15490 | pENTER-EGFR T790M/del19 | DNA solution |
Materials & Methods section:
The pENTER-EGFR T790M/del19 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB15490). |
Reference section:
Further references such as user reports and related articles (go to bottom)
Featured content
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB15490_A7K8p1-2.pdf ![]() |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: rrnBT1ter_F2 (Pr0531) Region: rrnB T1 ter,attL1,insert 5' Sequence file: RDB15490_A7K8d.seq ![]() |
---|
>D04925A3_A7K8_1_rrnBT1ter_F2_C04_07_ABI24.ab1 1 NNNNNNNNNN NNNNNNNNNN CCTTTCGTTT NNTTTGATGC CTGGCAGTTC CCTACTCTCG 61 CGTTAACGCT AGCATGGATG TTTTCCCAGT CACGACGTTG TAAAACGACG GCCAGTCTTA 121 AGCTCGGGCC CCAAATAATG ATTTTATTTT GACTGATAGT GACCTGTTCG TTGCAACAAA 181 TTGATGAGCA ATGCTTTTTT ATAATGCCAA CTTTGTACAA AAAAGCAGGC TCCGCGGCCG 241 CCCCCTTCAC CATGCGACCC TCCGGGACGG CCGGGGCAGC GCTCCTGGCG CTGCTGGCTG 301 CGCTCTGCCC GGCGAGTCGG GCTCTGGAGG AAAAGAAAGT TTGCCAAGGC ACGAGTAACA 361 AGCTCACGCA GTTGGGCACT TTTGAAGATC ATTTTCTCAG CCTCCAGAGG ATGTTCAATA 421 ACTGTGAGGT GGTCCTTGGG AATTTGGAAA TTACCTATGT GCAGAGGAAT TATGATCTTT 481 CCTTCTTAAA GACCATCCAG GAGGTGGCTG GTTATGTCCT CATTGCCCTC AACACAGTGG 541 AGCGAATTCC TTTGGAAAAC CTGCAGATCA TCAGAGGAAA TATGTACTAC GAAAATTCCT 601 ATGCCTTAGC AGTCTTATCT AACTATGATG CAAATAAAAC CGGACTGAAG GAGCTGCCCA 661 TGAGAAANTT ACAGGAAATC CTGCATGGCG CCGTGCGGTT CAGCAACAAC CCTGCCCTGT 721 GCAATGTGGA GAGCATCCAG TGGCGGGACA TAGTCAGCAG TGACTTTCTC AGCAACATGT 781 CGATGGACTT CCAGAACCAC CTGGGCAGCT GCCAAAAGTG TGNTCCAAGC TGTCCCAATN 841 NNANCTGCTG GGGTGCANGA NANGANAANT GCCAGAAACT GANCAAAATC ATCTGNGCCC 901 AGCAGNGCNC CGGGCGCTGC CNNGGCAAGN CCCCCNANNN NNNGCTGCCA CAACCANNNN 961 NNTGNNNNNN NNCNNNNCCC CNGGNNNNNC NNNNNNNNNN // |
Primer: pDONR_R (Pr0071) Region: attL2,insert 3' Sequence file: RDB15490_A7K8e.seq ![]() |
>D04925A3_A7K8_1_pDONR_R_C08_08_ABI24.ab1 1 NNNNNNNNNN NNNNNNNNCN NTGNNNNTGT AATACGACTC ACTATAGGGG ANATCAGCTG 61 GATGGCAAAT AATGATTTTA TTTTGACTGA TAGTGACCTG TTCGTTGCAA CAAATTGATA 121 AGCAATGCTT TCTTATAATG CCAACTTTGT ACAAGAAAGC TGGGTCGGCG CGCCCACCCT 181 TTCATGCTCC AATAAATTCA CTGCTTTGTG GCGCGACCCT TAGGTATTCT GCATTTTCAG 241 CTGTGGAGCC CTTAAAGATG CCATTTGGCT TGGCTTCCTT GGGAAAGAAG TCCTGCTGGT 301 AGTCAGGGTT GTCCAGGCTA ATTTGGTGGC TGCCTTTCTG GGCCCAGTGG GCAGGGCTGT 361 CGAATGTGCT GTTGACACAG GTGGGCTGGA CAGTGTTGAG ATACTCGGGG TTGCCCACTG 421 CAGTGCTGTG GGGGTCCTGG TAGTGTGGGT CTCTGCTGGG CGCGGGGTTC AGAGGCTGAT 481 TGTGATAGAC AGGATTCTGC ACAGAGCCAG CGGGCCTTTT GGGAACGGAC TGGTTTATGT 541 ATTCAGGCAC TGGGAGGAAG GTGTCGTCTA TGCTGTCCTC AGTCAAGGCG CCTGTGGGGT 601 CTGANCTGTA TCGCTGCAAG AAGCTGTCTT CCTTGATGGG ACAGCTTTGC AGCCCATTTC 661 TATCNATGCA AGCCACGGNG GAATTGTTGC TGGTTGCACT CAGANANCTC NNNANGGGAN 721 TCCGTGANGN GGANGGGCTG CTGNANAANC CCTGCTGTGG GNNGANGNAN TCGNCNGCNT 781 CCNCCNCNNC NTNCNTGNCN NCNNNNTNCN TCNNGNNNNN GNANANNNNN GNANNCNGNN 841 NNANTNNNNN AANGCNTNNN TNNNNNCNNN NNNNNNN // |
Primer: EGFR-F5 (Pr0313) Region: insert mid(T790M/del19) Sequence file: RDB15490_A7K8f.seq ![]() |
>D04925A3_A7K8_1_EGFR-F5_C09_09_ABI24.ab1 1 NNNNNNNNNN NNNNNNNNNN NNNNNGGNNG GTGGGGGCCC TCCTCTTGCT GCTGGTGGTG 61 GCCCTGGGGN NCGGCCTCTT CNTGCGAAGG CGCCACATCG TTCGGAAGCG CACGCTGCGG 121 AGGCTGCTGC AGGAGAGGGA GCTTGTGGAG CCTCTTACAC CCAGTGGAGA AGCTCCCAAC 181 CAAGCTCTCT TGAGGATCTT GAAGGAAACT GAATTCAAAA AGATCAAAGT GCTGGGCTCC 241 GGTGCGTTCG GCACGGTGTA TAAGGGACTC TGGATCCCAG AAGGTGAGAA AGTTAAAATT 301 CCCGTCGCTA TCAAGACATC TCCGAAAGCC AACAAGGAAA TCCTCGATGA AGCCTACGTG 361 ATGGCCAGCG TGGACAACCC CCACGTGTGC CGCCTGCTGG GCATCTGCCT CACCTCCACC 421 GTGCAGCTCA TCATGCAGCT CATGCCCTTC GGCTGCCTCC TGGACTATGT CCGGGAACAC 481 AAAGACAATA TTGGCTCCCA GTACCTGCTC AACTGGTGTG TGCAGATCGC AAAGGGCATG 541 AACTACTTGG AGGACCGTCG CTTGGTGCAC CGCGACCTGG CAGCCAGGAA CGTACTGGTG 601 AAAACACCGC AGCATGTCAA GATCACAGAT TTTGGGCTGG CCAAACTGCT GGGTGCGGAA 661 GAGAAAGAAT ACCATGCAGA AGGAGGCAAA GTGCCTATCA AGTGGATGGC ATTGGAATCA 721 ATTTTACACA GAATCTATAC CCACCAGAGT GATGTCTGGA GCTACGGNNT GANCGTTTGG 781 GAGTTGATGA NCTTTGGATC CAAGCCATAT GACGGAATCC CTGCCNGCGA GATCTCCTCC 841 NTCCTNGANA AAGGANAACG CCNCCNTCAG CCNCCCATAT GTANCNTCGA NGNCTACATG 901 ATCATGGNCN ANNGCTGGNT GATAGNNGCN NANAGNCGCC NNAANTTNCN NNNNNNGATC 961 ATCNNNNNNN NNN // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
original | Uchibori, K., Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer. Nat. Commun. 8: 14768 (2017). PMID 28287083. |
---|
2023.05.01
GNP_filter3_RDBDEP_html_230501.pl